Valuation: BioNexus Gene Lab Corp.

Market Cap 4.67M 4.09M 3.78M 3.49M 6.62M 447M 6.75M 45.42M 17.65M 219M 17.52M 17.14M 759M P/E 2024
-3.12x
P/E 2025 -2.46x
Enterprise Value 851K 747K 689K 637K 1.21M 81.51M 1.23M 8.29M 3.22M 39.89M 3.2M 3.13M 138M EV / Sales 2024
0.09x
EV / Sales 2025 0.74x
Free-Float
64.41%
Yield 2024 *
-
Yield 2025 -
1 day+1.05%
1 week-3.50%
Current month-1.03%
1 month-11.87%
3 months-16.09%
6 months-50.51%
Current year-51.14%
1 week 1.81
Extreme 1.81
2.12
1 month 1.07
Extreme 1.07
2.7
Current year 1.07
Extreme 1.07
4.14
1 year 1.07
Extreme 1.07
8.98
3 years 1.07
Extreme 1.07
178.8
5 years 1.07
Extreme 1.07
270
10 years 1.07
Extreme 1.07
414
Manager TitleAgeSince
Chief Executive Officer 43 2023-12-10
Director of Finance/CFO 63 2025-06-16
Director TitleAgeSince
Director/Board Member 71 2022-03-06
Director/Board Member 43 2023-12-10
Director/Board Member 51 2023-12-10
Date Insider Type Main position Quantity % Market Cap.
23-07-18Other

Chief Financial Officer

4,797,709 -
23-07-18Other

Chief Operating Officer

12,500,460 -
Change 5-day change 1-year change 3-year change Capi.($)
+1.05%-3.50%-69.80%-96.26% 4.62M
-0.24%+1.85%+3.13%+9.14% 49.74B
-0.36%+1.21%+420.77%+619.10% 40.49B
-2.13%+0.29%+23.91%-6.01% 34.75B
-2.29%+3.83%+23.48%+59.26% 34.35B
-0.79%+1.32%+5.78%+36.42% 26.98B
+3.82%+3.51% - - 16.58B
-2.62%-2.13%+64.96%+125.87% 15.6B
-2.17%+6.65%+104.31%+102.15% 14.27B
-2.70%-2.04%+12.37%+18.19% 13.76B
Average -0.84%+1.96%+65.43%+96.43% 24.65B
Weighted average by Cap. -1.00%+2.96%+94.19%+139.17%

Financials

2024 2025
Net sales 9.51M 8.34M 7.7M 7.12M 13.49M 911M 13.76M 92.58M 35.97M 446M 35.72M 34.93M 1.55B 7.42M 6.51M 6.01M 5.56M 10.53M 711M 10.74M 72.28M 28.08M 348M 27.88M 27.27M 1.21B
Net income -1.6M -1.4M -1.29M -1.2M -2.27M -153M -2.31M -15.56M -6.05M -74.89M -6M -5.87M -260M -2.98M -2.62M -2.42M -2.23M -4.23M -286M -4.32M -29.05M -11.29M -140M -11.21M -10.96M -485M
Net Debt -4.15M -3.64M -3.36M -3.11M -5.89M -397M -6M -40.4M -15.7M -194M -15.58M -15.24M -675M -3.81M -3.35M -3.09M -2.85M -5.41M -365M -5.52M -37.13M -14.43M -179M -14.32M -14.01M -620M
Logo BioNexus Gene Lab Corp.
BioNexus Gene Lab Corp. is a biotechnology company specializing in precision diagnostics and specialty chemical solutions. The Company, through its wholly owned subsidiary Chemrex Corporation Sdn. Bhd., focuses on the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries in the Southeast Asia region. These countries include Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. Its segments include Trading of industrial chemicals, Provision for genomic screening services, and Investment holding. The Provision for genomic screening services segment includes commercializing proprietary blood-based diagnostic test for early disease detection. Its subsidiary MRNA Scientific Sdn. Bhd owns algorithm software, technology, and know-how related to the detection of common diseases through blood analysis which it uses in its business.
Employees
19
Date Price Change Volume
26-07-08 US$1.930 +1.05% 3,456
26-07-07 US$1.910 -9.05% 6,335
26-07-06 US$2.100 +3.45% 7,523
26-07-02 US$2.030 +1.49% 2,855
26-07-01 US$2.000 +2.57% 2,567
  1. Stock Market
  2. Stocks
  3. BGLC Stock